{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T06:30:09Z","timestamp":1764052209615,"version":"3.37.3"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T00:00:00Z","timestamp":1529971200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001922","name":"Efficacy and Mechanism Evaluation Programme","doi-asserted-by":"publisher","award":["14\/144\/08"],"award-info":[{"award-number":["14\/144\/08"]}],"id":[{"id":"10.13039\/501100001922","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13063-018-2689-1","type":"journal-article","created":{"date-parts":[[2018,6,25]],"date-time":"2018-06-25T20:06:17Z","timestamp":1529957177000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Efficacy and mechanism of sub-sensory sacral (optimised) neuromodulation in adults with faecal incontinence: study protocol for a randomised controlled trial"],"prefix":"10.1186","volume":"19","author":[{"given":"Eleanor","family":"McAlees","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul F.","family":"Vollebregt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom C.","family":"Dudding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton V.","family":"Emmanuel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul L.","family":"Furlong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaheen","family":"Hamdy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard L.","family":"Hooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James F. X.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Norton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Ronan","family":"O\u2019Connell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Mark","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles H.","family":"Knowles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,26]]},"reference":[{"key":"2689_CR1","volume-title":"Incontinence. Plybridge","author":"C Norton","year":"2009","unstructured":"Norton C, Whitehead W, Bliss D, Harari D, Lang J. Conservative and pharmacological management of fecal incontinence in adults. In: Incontinence. Plybridge; 2009."},{"key":"2689_CR2","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1053\/j.gastro.2009.04.054","volume":"137","author":"WE Whitehead","year":"2009","unstructured":"Whitehead WE, Borrud L, Goode PS, Meikle S, Mueller ER, Tuteja A, Weidner A, Weinstein M, Ye W, Network PFD. Fecal incontinence in US adults: epidemiology and risk factors. Gastroenterology. 2009;137:512\u2013517. e512.","journal-title":"Gastroenterology"},{"key":"2689_CR3","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/S0140-6736(82)92413-8","volume":"319","author":"R Leigh","year":"1982","unstructured":"Leigh R, Turnberg L. Faecal incontinence: the unvoiced symptom. Lancet. 1982;319:1349\u201351.","journal-title":"Lancet"},{"key":"2689_CR4","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1136\/bmj.39231.633275.AD","volume":"334","author":"C Norton","year":"2007","unstructured":"Norton C, Thomas L, Hill J. NICE guidelines: management of faecal incontinence in adults: summary of NICE guidance. BMJ. 2007;334:1370.","journal-title":"BMJ"},{"key":"2689_CR5","doi-asserted-by":"publisher","unstructured":"Norton C, Cody JD. Biofeedback and\/or sphincter exercises for the treatment of faecal incontinence in adults. Cochrane Database Syst Rev. 2012;(7):CD002111. \n                    https:\/\/doi.org\/10.1002\/14651858.CD002111.pub3\n                    \n                  .","DOI":"10.1002\/14651858.CD002111.pub3"},{"key":"2689_CR6","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1002\/bjs.9226","volume":"100","author":"NN Thin","year":"2013","unstructured":"Thin NN, Horrocks EJ, Hotouras A, Palit S, Thaha MA, Chan CL, Matzel KE, Knowles CH. Systematic review of the clinical effectiveness of neuromodulation in the treatment of faecal incontinence. Br J Surg. 2013;100:1430\u201347.","journal-title":"Br J Surg"},{"key":"2689_CR7","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1002\/bjs.6237","volume":"95","author":"TC Dudding","year":"2008","unstructured":"Dudding TC, Meng Lee E, Faiz O, Pares D, Vaizey CJ, McGuire A, Kamm MA. Economic evaluation of sacral nerve stimulation for faecal incontinence. Br J Surg. 2008;95:1155\u201363.","journal-title":"Br J Surg"},{"key":"2689_CR8","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/DCR.0b013e318276b24c","volume":"56","author":"T Hull","year":"2013","unstructured":"Hull T, Giese C, Wexner SD, Mellgren A, Devroede G, Madoff RD, Stromberg K, Coller JA. Long-term durability of sacral nerve stimulation therapy for chronic fecal incontinence. Dis Colon Rectum. 2013;56:234.","journal-title":"Dis Colon Rectum"},{"key":"2689_CR9","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1097\/SLA.0b013e3181cf8ed0","volume":"251","author":"SD Wexner","year":"2010","unstructured":"Wexner SD, Coller JA, Devroede G, Hull T, McCallum R, Chan M, Ayscue JM, Shobeiri AS, Margolin D, England M, et al. Sacral nerve stimulation for fecal incontinence: results of a 120-patient prospective multicenter study. Ann Surg. 2010;251:441\u20139.","journal-title":"Ann Surg"},{"key":"2689_CR10","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/bjs.9740","volume":"102","author":"DF Altomare","year":"2015","unstructured":"Altomare DF, Giuratrabocchetta S, Knowles CH, Munoz Duyos A, Robert-Yap J, Matzel KE. Long-term outcomes of sacral nerve stimulation for faecal incontinence. Br J Surg. 2015;102:407\u201315.","journal-title":"Br J Surg"},{"key":"2689_CR11","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1097\/SLA.0b013e31829d3969","volume":"259","author":"Y Maeda","year":"2014","unstructured":"Maeda Y, Lundby L, Buntzen S, Laurberg S. Outcome of sacral nerve stimulation for fecal incontinence at 5 years. Ann Surg. 2014;259:1126\u201331.","journal-title":"Ann Surg"},{"key":"2689_CR12","doi-asserted-by":"crossref","unstructured":"Thaha MA, Abukar AA, Thin NN, Ramsanahie A, Knowles CH. Sacral nerve stimulation for faecal incontinence and constipation in adults. Cochrane Database Syst Rev. 2015:Cd004464. \n                    http:\/\/www.cochrane.org\/CD004464\/INCONT_sacral-nerve-stimulation-treating-faecal-incontinence-and-constipation-adults\n                    \n                  .","DOI":"10.1002\/14651858.CD004464.pub3"},{"key":"2689_CR13","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/BF02258292","volume":"43","author":"CJ Vaizey","year":"2000","unstructured":"Vaizey CJ, Kamm MA, Roy AJ, Nicholls RJ. Double-blind crossover study of sacral nerve stimulation for fecal incontinence. Dis Colon Rectum. 2000;43:298\u2013302.","journal-title":"Dis Colon Rectum"},{"key":"2689_CR14","unstructured":"Sorensen MT. Sacral nerve stimulation increases rectal sensitivity in patients with faecal incontinence: results of a randomised double-blinded crossover study. In: Proceedings of the Joint Meeting of the International Continence Society (ICS) and the International Urogynecological Association 2010, Abstract 437; Toronto, Canada."},{"key":"2689_CR15","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1097\/01.sla.0000186281.09475.db","volume":"242","author":"AM Leroi","year":"2005","unstructured":"Leroi AM, Parc Y, Lehur PA, Mion F, Barth X, Rullier E, Bresler L, Portier G, Michot F. Efficacy of sacral nerve stimulation for fecal incontinence: results of a multicenter double-blind crossover study. Ann Surg. 2005;242:662\u20139.","journal-title":"Ann Surg"},{"key":"2689_CR16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/DCR.0000000000000295","volume":"58","author":"V Kahlke","year":"2015","unstructured":"Kahlke V, Topic H, Peleikis HG, Jongen J. Sacral nerve modulation for fecal incontinence: results of a prospective single-center randomized crossover study. Dis Colon Rectum. 2015;58:235\u201340.","journal-title":"Dis Colon Rectum"},{"key":"2689_CR17","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s10350-007-9103-5","volume":"51","author":"JJ Tjandra","year":"2008","unstructured":"Tjandra JJ, Chan MK, Yeh CH, Murray-Green C. Sacral nerve stimulation is more effective than optimal medical therapy for severe fecal incontinence: a randomized, controlled study. Dis Colon Rectum. 2008;51:494\u2013502.","journal-title":"Dis Colon Rectum"},{"key":"2689_CR18","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/bjs.9695","volume":"102","author":"NN Thin","year":"2015","unstructured":"Thin NN, Taylor SJ, Bremner SA, Emmanuel AV, Hounsome N, Williams NS, Knowles CH. Randomized clinical trial of sacral versus percutaneous tibial nerve stimulation in patients with faecal incontinence. Br J Surg. 2015;102:349\u201358.","journal-title":"Br J Surg"},{"key":"2689_CR19","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1007\/BF02150742","volume":"33","author":"KE Matzel","year":"1990","unstructured":"Matzel KE, Schmidt RA, Tanagho EA. Neuroanatomy of the striated muscular anal continence mechanism. Implications for the use of neurostimulation. Dis Colon Rectum. 1990;33:666\u201373.","journal-title":"Dis Colon Rectum"},{"key":"2689_CR20","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1463-1318.2007.01319.x","volume":"10","author":"TC Dudding","year":"2008","unstructured":"Dudding TC, Pares D, Vaizey CJ, Kamm MA. Predictive factors for successful sacral nerve stimulation in the treatment of faecal incontinence: a 10-year cohort analysis. Color Dis. 2008;10:249\u201356.","journal-title":"Color Dis"},{"key":"2689_CR21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1177\/014107680409700303","volume":"97","author":"PJ Lunniss","year":"2004","unstructured":"Lunniss PJ, Gladman MA, Hetzer FH, Williams NS, Scott SM. Risk factors in acquired faecal incontinence. J R Soc Med. 2004;97:111\u20136.","journal-title":"J R Soc Med"},{"key":"2689_CR22","doi-asserted-by":"publisher","first-page":"e741","DOI":"10.1111\/codi.12418","volume":"15","author":"DF Altomare","year":"2013","unstructured":"Altomare DF, Giannini I, Giuratrabocchetta S, Digennaro R. The effects of sacral nerve stimulation on continence are temporarily maintained after turning the stimulator off. Color Dis. 2013;15:e741\u20138.","journal-title":"Color Dis"},{"key":"2689_CR23","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/nau.22938","volume":"36","author":"TH La","year":"2017","unstructured":"La TH, Groen J, Scheepe JR, Blok BF. Intermittent sacral neuromodulation for idiopathic urgency urinary incontinence in women. Neurourol Urodyn. 2017;36:385\u20139.","journal-title":"Neurourol Urodyn"},{"key":"2689_CR24","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/SPV.0000000000000188","volume":"21","author":"DM Price","year":"2015","unstructured":"Price DM, Noblett K. Prospective randomized crossover trial comparing continuous and cyclic stimulation in InterStim therapy. Female Pelvic Med Reconstr Surg. 2015;21:355\u20138.","journal-title":"Female Pelvic Med Reconstr Surg"},{"issue":"Suppl 2","key":"2689_CR25","doi-asserted-by":"publisher","first-page":"S453","DOI":"10.1007\/s00192-010-1280-4","volume":"21","author":"ER Williams","year":"2010","unstructured":"Williams ER, Siegel SW. Procedural techniques in sacral nerve modulation. Int Urogynecol J. 2010;21(Suppl 2):S453\u201360.","journal-title":"Int Urogynecol J"},{"key":"2689_CR26","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/ner.12695","volume":"20","author":"KE Matzel","year":"2017","unstructured":"Matzel KE, Chartier-Kastler E, Knowles CH, Lehur PA, Munoz-Duyos A, Ratto C, Rydningen MB, Sorensen M, van Kerrebroeck P, de Wachter S. Sacral neuromodulation: standardized electrode placement technique. Neuromodulation. 2017;20:816\u201324.","journal-title":"Neuromodulation"},{"key":"2689_CR27","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/SLA.0b013e318269d493","volume":"257","author":"J Duelund-Jakobsen","year":"2013","unstructured":"Duelund-Jakobsen J, Buntzen S, Lundby L, Laurberg S. Sacral nerve stimulation at subsensory threshold does not compromise treatment efficacy: results from a randomized, blinded crossover study. Ann Surg. 2013;257:219\u201323.","journal-title":"Ann Surg"},{"key":"2689_CR28","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/nmo.12307","volume":"26","author":"EV Carrington","year":"2014","unstructured":"Carrington EV, Brokjaer A, Craven H, Zarate N, Horrocks EJ, Palit S, Jackson W, Duthie GS, Knowles CH, Lunniss PJ, Scott SM. Traditional measures of normal anal sphincter function using high-resolution anorectal manometry (HRAM) in 115 healthy volunteers. Neurogastroenterol Motil. 2014;26:625\u201335.","journal-title":"Neurogastroenterol Motil"},{"key":"2689_CR29","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/codi.12566","volume":"16","author":"CJ Vaizey","year":"2014","unstructured":"Vaizey CJ. Faecal incontinence: standardizing outcome measures. Color Dis. 2014;16:156\u20138.","journal-title":"Color Dis"},{"key":"2689_CR30","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/S0140-6736(10)62297-0","volume":"377","author":"W Graf","year":"2011","unstructured":"Graf W, Mellgren A, Matzel KE, Hull T, Johansson C, Bernstein M. Efficacy of dextranomer in stabilised hyaluronic acid for treatment of faecal incontinence: a randomised, sham-controlled trial. Lancet. 2011;377:997\u20131003.","journal-title":"Lancet"},{"key":"2689_CR31","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1136\/gut.44.1.77","volume":"44","author":"CJ Vaizey","year":"1999","unstructured":"Vaizey CJ, Carapeti E, Cahill JA, Kamm MA. Prospective comparison of faecal incontinence grading systems. Gut. 1999;44:77\u201380.","journal-title":"Gut"},{"key":"2689_CR32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/BF02237236","volume":"43","author":"TH Rockwood","year":"2000","unstructured":"Rockwood TH, Church JM, Fleshman JW, Kane RL, Mavrantonis C, Thorson AG, Wexner SD, Bliss D, Lowry AC. Fecal Incontinence Quality of Life Scale: quality of life instrument for patients with fecal incontinence. Dis Colon Rectum. 2000;43:9\u201316. discussion 16-17","journal-title":"Dis Colon Rectum"},{"key":"2689_CR33","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1097\/DCR.0b013e3182272128","volume":"54","author":"N Cotterill","year":"2011","unstructured":"Cotterill N, Norton C, Avery KN, Abrams P, Donovan JL. Psychometric evaluation of a new patient-completed questionnaire for evaluating anal incontinence symptoms and impact on quality of life: the ICIQ-B. Dis Colon Rectum. 2011;54:1235\u201350.","journal-title":"Dis Colon Rectum"},{"key":"2689_CR34","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1016\/S0140-6736(15)60314-2","volume":"386","author":"CH Knowles","year":"2015","unstructured":"Knowles CH, Horrocks EJ, Bremner SA, Stevens N, Norton C, O'Connell PR, Eldridge S. Percutaneous tibial nerve stimulation versus sham electrical stimulation for the treatment of faecal incontinence in adults (CONFIDeNT): a double-blind, multicentre, pragmatic, parallel-group, randomised controlled trial. Lancet. 2015;386:1640\u20138.","journal-title":"Lancet"},{"key":"2689_CR35","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/hbm.20102","volume":"25","author":"A Hillebrand","year":"2005","unstructured":"Hillebrand A, Singh KD, Holliday IE, Furlong PL, Barnes GR. A new approach to neuroimaging with magnetoencephalography. Hum Brain Mapp. 2005;25:199\u2013211.","journal-title":"Hum Brain Mapp"},{"key":"2689_CR36","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/bjs.4757","volume":"92","author":"SM Koch","year":"2005","unstructured":"Koch SM, van Gemert WG, Baeten CG. Determination of therapeutic threshold in sacral nerve modulation for faecal incontinence. Br J Surg. 2005;92:83\u20137.","journal-title":"Br J Surg"},{"key":"2689_CR37","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1002\/bjs.8760","volume":"99","author":"PG Dinning","year":"2012","unstructured":"Dinning PG, Hunt LM, Arkwright JW, Patton V, Szczesniak MM, Wiklendt L, Davidson JB, Lubowski DZ, Cook IJ. Pancolonic motor response to subsensory and suprasensory sacral nerve stimulation in patients with slow-transit constipation. Br J Surg. 2012;99:1002\u201310.","journal-title":"Br J Surg"},{"key":"2689_CR38","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/SLA.0000000000000559","volume":"260","author":"JL Fassov","year":"2014","unstructured":"Fassov JL, Lundby L, Laurberg S, Buntzen S, Krogh K. A randomized, controlled, crossover study of sacral nerve stimulation for irritable bowel syndrome. Ann Surg. 2014;260:31\u20136.","journal-title":"Ann Surg"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-018-2689-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-018-2689-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-018-2689-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T08:45:54Z","timestamp":1569314754000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-018-2689-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,26]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2689"],"URL":"https:\/\/doi.org\/10.1186\/s13063-018-2689-1","relation":{},"ISSN":["1745-6215"],"issn-type":[{"type":"electronic","value":"1745-6215"}],"subject":[],"published":{"date-parts":[[2018,6,26]]},"assertion":[{"value":"6 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Eleanor McAlees is Senior Research Nurse at National Bowel Research Centre, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, UK.Paul F Vollebregt is Clinical Research Fellow at National Bowel Research Centre, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, UK.Natasha Stevens is Senior Research Programme Manager at National Bowel Research Centre, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, UK.Tom C Dudding is Consultant Colorectal Surgeon at University Hospital Southampton NHS Foundation Trust, Southampton, UK.Anton V Emmanuel is Consultant Gastroenterologist at University College Hospital London and Academic Neurogastroenterologist at University College London, London, UK.Paul L Furlong is Professor of Clinical Neuroimaging and Director of Aston Brain Centre, Aston University, Birmingham, UK.Shaheen Hamdy is Professor of Neurogastroenterology and Consultant Gastroenterologist at University of Manchester \/ Salford Royal Hospital, Manchester and Salford, UK.Richard L Hooper is Reader in Medical Statistics at Pragmatic Clinical Trials Unit, Centre for Primary Care and Public Health, Queen Mary University of London, UK.James FX Jones is Professor of Anatomy at University College Dublin School of Medicine, Dublin, Ireland.Christine Norton is Professor of Clinical Nursing Research, King\u2019s College London, UK.P Ronan O\u2019Connell is Professor of Surgery and Consultant Colorectal Surgeon at University College Dublin School of Medicine \/ St. Vincent\u2019s University Hospital, Dublin, Ireland.S Mark Scott is Senior Clinical Scientist and Director of the GI Physiology Unit (Colorectal Service) at Queen Mary University of London \/ Barts Health NHS Trust, London, UK.Charles H Knowles is Professor of Surgery and Honorary Consultant Colorectal Surgeon at Queen Mary University of London \/ Barts Health NHS Trust, London, UK.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 information"}},{"value":"The research is performed in accordance with the Declaration of Helsinki. Informed consent will be obtained from all participants in the study. The chief investigator (CI: CK) has obtained approval for the trial from a recognised committee of the UK HRA National Research Ethics Service, London City and East REC (Reference 17\/LO\/1060, IRAS 187783) on 13 September 2017.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"EM, PFV, NS, AVE, PLF, RLH, JFJ and CN have no conflict of interest. TCD has received financial remuneration from Medtronic Inc. and Axonics Neuromodulation Technologies as honoraria and participation on expert advisory committees. SH has received funding from the University of Manchester, Enteric HTC, and the Small Business Research Initiative (SBRI) fund to develop a diagnostic device to assess faecal incontinence. PRO has received financial remuneration from Medtronic Inc. as speaker fees and financial support for contract research, and has also received financial remuneration from Ethicon Endosurgery as speaker and consultation fees, and consultation fees from MSD. SMS has received honoraria for teaching from MMS\/Laborie. CHK has received financial remuneration from Medtronic Inc. as speaker fees and for expert advisory committees.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"336"}}